Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lexicon Pharmaceutcl
(NQ:
LXRX
)
1.205
+0.005 (+0.42%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lexicon Pharmaceutcl
< Previous
1
2
3
4
5
6
Next >
Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
June 01, 2023
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 01, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers that traders need to know about for Thursday morning!
Via
InvestorPlace
Salesforce, C3.ai, Okta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 01, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Earnings Preview For Lexicon Pharmaceuticals
May 01, 2023
Via
Benzinga
Lexicon Pharmaceuticals's Return On Capital Employed Insights
March 08, 2023
Via
Benzinga
Earnings Preview For Lexicon Pharmaceuticals
March 01, 2023
Via
Benzinga
Lexicon Pharmaceuticals's Return On Capital Employed Overview
December 14, 2022
Via
Benzinga
Microsoft To Rally Around 27%? Here Are 10 Other Analyst Forecasts For Wednesday
May 31, 2023
Credit Suisse boosted the price target for Microsoft Corp (NASDAQ: MSFT) from $350 to $420. Credit Suisse analyst Sami Badri maintained the stock with an Outperform rating. Microsoft shares fell 0.5%...
Via
Benzinga
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 30, 2023
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
Via
Benzinga
Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday
May 30, 2023
U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket
May 30, 2023
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter...
Via
Benzinga
Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
May 30, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Gaotu Techedu Inc. (NYSE: GOTU) shares jumped 19.7% to $2.98 in pre-market...
Via
Benzinga
HP, Lexicon Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday
May 30, 2023
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 29, 2023
Via
Benzinga
Wall Street's Counting on an FDA Nod for This Growth Stock to Nearly Double, but Should You?
May 11, 2023
Lexicon is approaching a fork in the road, and it needs permission to advance.
Via
The Motley Fool
Should You Buy This Growth Stock Right Now Before It Potentially Doubles?
April 22, 2023
It could skyrocket or it could tank, but it probably won't be sitting still soon.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 03, 2023
Via
Benzinga
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
March 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 03, 2023
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
Via
Benzinga
Lexicon Pharma's Pain Candidate Fails In Postherpetic Neuralgia Study
December 22, 2022
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) announced the topline results of RELIEF-PHN-1 Phase 2 proof-of-concept study of LX9211 in postherpetic neuralgia, a lasting pain in the areas of the skin that...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
Via
Benzinga
Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 22, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Westrock Coffee Company, LLC (NASDAQ: WEST) shares tumbled 10.9% to $11.90...
Via
Benzinga
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study
November 15, 2022
Via
Benzinga
Earnings Outlook For Lexicon Pharmaceuticals
November 08, 2022
Lexicon Pharmaceuticals (NASDAQ:LXRX) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
Via
Benzinga
Recap: Lexicon Pharmaceuticals Q2 Earnings
August 02, 2022
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lexicon...
Via
Benzinga
More Than $40 Million Bet On This Penny Stock? Check Out These 3 Penny Stocks Insiders Are Buying
August 02, 2022
U.S. gold futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.